Literature DB >> 26437686

Improved molecular diagnosis of the common recurrent intragenic deletion mutation in IKBKG in a Filipino family with incontinentia pigmenti.

Bryan Edgar K Guevara1, Chao-Kai Hsu2,3,4, Lu Liu5, Alice Feast2, Karen Lee P Alabado1, Maricarr Pamela M Lacuesta1, Julia Yu-Yun Lee3, John A McGrath2.   

Abstract

Incontinentia pigmenti is a rare, multisystem X-linked dominant genetic disorder caused by mutations in IKBKG, the encoding inhibitor of kappa light polypeptide gene enhancer in B-cells. Almost 80% of all cases result from a recurrent intragenic deletion mutation that removes exon 4-10. At present, this mutation can be detected by a multi-primer polymerase chain reaction (PCR) technique although current protocols may preferentially amplify the wild-type allele and miss the deletion. Here, we report a female infant with incontinentia pigmenti that also affected her mother and sister, and two spontaneously aborted male siblings. We developed a modified PCR amplification method that provides more robust detection of the exon 4-10 deletion mutation, which was demonstrated in all affected females in this pedigree.
© 2015 The Australasian College of Dermatologists.

Entities:  

Keywords:  Blaschko's lines; X-linked; gene deletion; mosaic; vesicle

Mesh:

Substances:

Year:  2015        PMID: 26437686     DOI: 10.1111/ajd.12407

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  2 in total

1.  Clinical profile of comorbidity of rare diseases in a Tunisian patient: a case report associating incontinentia pigmenti and Noonan syndrome.

Authors:  Nehla Ghedira; Arnaud Lagarde; Karim Ben Ameur; Sahar Elouej; Rania Sakka; Emna Kerkeni; Fatma-Zohra Chioukh; Sylviane Olschwang; Jean-Pierre Desvignes; Sonia Abdelhak; Valerie Delague; Nicolas Lévy; Kamel Monastiri; Annachiara De Sandre-Giovannoli
Journal:  BMC Pediatr       Date:  2018-08-29       Impact factor: 2.125

2.  Challenges in Rare Diseases Diagnostics: Incontinentia Pigmenti with Heterozygous GBA Mutation.

Authors:  Snežana Minić; Dušan Trpinac; Ivana Novaković; Nataša Cerovac; Danijela Dobrosavljević Vukojević; Jérémie Rosain
Journal:  Diagnostics (Basel)       Date:  2022-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.